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1 
INTRODUCTION 
The product ion of an anesthetic state in the equine 
species poses problems for the veterinary anesthesiologist 
not encountered in the handling of smaller species. Horses 
are not only large and thus difficult to restrain but tend 
also to be nervous and intractable when subjected to the 
restraint necessary for the induction of general anesthesia. 
Administration of a combination of glyceryl guaiacolate 
and thiamylal sodium intravenously has been suggested as an 
adequate chemical restraining agent, used alone for short 
anesthetic procedures and for the induction of i nhalation 
anesthesia in the horse. Any agent to b e used in this manner 
should produce a state of basal narcosis or surgical anesthesia 
without contributing to the already nervous and excited state 
of the subject. The agent should depress both laryngeal and 
pharyngeal reflexes making the passage of an endotracheal 
tube possible and should be relatively short acting with a 
smooth recovery period. It should be compatible with other 
anesthetic agents used in the horse and ideally should produce 
no adverse physiological effects on either the respiratory 
or cardiovascular systems. 
2 
The purpose of this study was to evaluate a combination 
of glyceryl guaiacolate and thiamylal sodium as to its 
ability to meet the above requirements. More specifically the 
combination was evaluated as to its ability to produce a state 
of recumbency and analgesia without depression of respiratory 
function or alteration of certain hematological factors . 
3 
REVIEW OF THE LITERATURE 
General Considerations 
The utilization of monitoring techniques and clinical 
pathological tests to determine physiological actions of 
various anesthetics has produced an abundance of data which 
the veterinary anesthesiologist can utilize . 
A study to determine the effect of inhalant anesthesia 
on arterial oxygen tension has shown a definite depressant 
(37) 
effect . No correlation with age or sex of the subject 
could be shown in this study. It was concluded that 
ventilation perfusion abnormalities were the cause of the 
lowered arterial oxygen tension and that high concentrations 
of inspired oxygen in the anesthetic circuit could minimize 
the effect. To prevent the possible production of a hypoxic 
state when using inhalant anesthesia in the horse, the 
(18) induction agents utilized should not c ause apnea In the 
adult horse oxygen flow rates of four liters per minute have 
been rec~mmended as being sufficient to prevent hypoxia. 
Studies to determine the most accurate sampling 
technique for the determination of blood gas tension have 
been done (32 • 33 ) Arterial blood samples, capillary blood 
samples and tracheal end tidal samples were collected. 
4 
Oxygen and carbon dioxide partial pressures and blood 
pH values were determined. It was concluded that the accuracy 
of the capillary samples was acceptable only in the case of 
. . (33) . 1 f blood pH determination • The partia pressures o oxygen 
and carbon dioxide determined from arterial and tracheal end 
tidal samples compared favorably and either method is 
acceptable for use in clinical investigation of pulmonary 
function in horses. The mean value for partial pressure of 
oxygen in arterial samples was 95.64 + 5.4 mm. Hg. The mean 
value for partial pressure of carbon dioxide in arterial 
(32) 
samples was 44.9 + 2 . 47 mm. Hg . • 
In the dog, narcotics, neuroleptoanalgesics , and other 
analgesics have been shown to produce depression of 
ventilation which can be documented by depression of 
(44) 
arterial blood gas and pH . 
In the horse, general anesthesia, in the laterally 
recumbent position, has been shown to produce a cardiopulmonary 
dysfunction which is characterized by hypoventilation and 
depression of alveolar and arterial oxygen ten sion (23 ) . This 
phenomenon was thought to be the result of maldistribution of 
blood perfusion due to gravitational forces on the dependent 
lung , development of atelectasis , hypoventilation of the 
dependent lung, and decrease in cardiac output. These 
5 
physiological changes occur with the use of several of the 
commonly used general anesthetics in the horse. 
Horses to which toxic doses of chloral hydrate and 
chloroform were administered in combination exhibited marked 
. d . . d . (49) respiratory depression an respiratory aci osis . Arterial 
oxygen tension after thirty minutes was 52 mm. Hg. Arterial 
carbon dioxide tension was 38 mm. Hg. and blood pH was 7.35 
at the same time interval. The horse died ultimately in 
cardiac arrest, exhibiting a metabolic acidosis. 
Arterial oxygen tension is significantly lowered by 
anesthesia induced with barbiturates and maintained with 
halothane-ox ygen mixtures in the horse< 27 ) . It has been 
recorranended that the inspired anesthetic mixture be at least 
90% oxygen when halothane is utilized as an anesthetic in the 
horse. Halothane anesthesia also produces a highly 
significant decrease in cardiac output and left ventricular 
work(l
4
). Peripheral vascular resistance is increased however, 
thus a hypotension does not occur unless arterial oxygen 
tension decrease s and arterial carbon dioxide tension 
increases sufficiently to produce r e spiratory acidosis. 
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Pharmacological Considerations 
Glyceryl guaiacolate (3-(0-methoxy phenoxy)-1, 2 
propanediol) is a guiaiacol derivative closely related to 
mephenesin. Its original use in the veterinary drug 
armamentarium was as an expectorant in various cough 
medications. 
The propanediol derivatives of guiaiacol, of which 
mephenesin and glyceryl guaiacolate are the two most widely 
used examples, selectively depress transmission of nerve 
impulses at the internuncial neurons of the spinal cord, brain 
d b . 1 f h b . (24, 25) stem, an su cortica areas o t e rain . Glyceryl 
guaiacolate is a white crystalline powder which, like 
mephenesin, is soluble in alcohol, glycerin and propylene 
glycol. Unlike mephenesin, glyceryl guiaiacolate is also 
readily soluble in water and therefore requires no special 
solvent for the preparation of a solution suitable for 
. t . . t" (25) in ravenous inJec ion . 
Solutions of both mephenesin and glyceryl guaiacolate 
produce hemolysis when administered intravenously. The 
degree of hernolysis depends primarily on the concentration of 
the solution injected. Glyceryl guaiacolate has only slightly 
less relaxant properties than does rnephenesin but has sixty 
five to seventy five percent less hemolytic activity( 24 • 36 • 48 ) 
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Therefore, glyceryl guaiacolate has been recommended as the 
best of the propanediol derivatives of guaiacol for clinical 
use 
(5) In vitro and in vivo studies have been done to 
ascertain the best concentration and solvent for use with 
. 1 ( 5, 36) glyceryl guaiaco ate . A 3.66% aqueous solution of 
glyceryl guaiacolate has been shown to possess no hemolytic 
activity while a 12.5% aqueous solution has been shown to 
produce intravenous hemolysis at each administration. The 
incorporation of isotonic sodium chloride or five percent 
glucose in combination with glyceryl guaiacolate solution 
markedly reduces the degree of intravenous hemolysis 
( 25) 
produced . Evidence has been presented that solutions of 
glyceryl guaiacolate in concentration of 5-10%, either with 
or without the incorporation of sodium chloride or glucose, 
b dm .. t d . h l' 1 d f h 1 . (
2 ) may e a 1n1s ere wit itt e anger o emo ysis . 
Serum bilirubin and hemochromogen determinations have 
supported this finding( 4S). 
All of the propanediol derivatives of guaiacol have been 
h t h t 
. . . (24) . s own o possess some ypo ensive activity . Studies have 
been conducted in humans and in many animal species to 
determine the degree of cardiac depression produced by glyceryl 
. 1 t am · . . (17, 43, 54) guaiaco a e a inistration . When therapeutic 
doses of glyceryl guaiacolate are administered intravenously 
8 
a slight transitory fall in blood pressure can be demonstrated 
in all species. In larger doses this hypotensive activity is 
markedly increased. The average reduction of systolic and 
diastolic pressure is 20 mm. Hg. and the pressure reduction 
b 50 
(13, 35) 
may e as great as mm. Hg. . This fall in blood 
pressure is transitory and electrocardiographic studies have 
reported no pathological changes, with the exception of a short 
. f . d . h . d < 3 o, 46) A period o tachycardia uring t e recovery perio s 
long as only therapeutic doses of glyceryl guaiacolate are 
administered, its action on the cardiovascular system has 
b h b 
. d . . . f. ( 10, 54) een s own to e transitory an insigni icant . 
Although glyceryl guaiacolate has the ability to relax 
the peripheral musculature to the point of paralysis, it has 
1 . 1 f . (13, 29) itt e e feet on the musculature of the diaphragm 
A slight decrease in respiratory volume and arterial oxygen 
tension has been demonstrated during glyceryl guaiacolate 
dm 
. . t . ( 1 7 , 46) 
a inis ration . Therapeutic doses have been shown to 
produce neither apnea nor depression of the respiratory 
(1, 10, 29) 
center With doses sufficient to cause the subject 
to assume a recumbent position, the laryngeal and pharyngeal 
reflexes are sufficiently depressed to allow endotracheal 
intubation(l, 54). Endotracheal intubation is not essential, 
unless desired, as apnea does not occur and respiration need 
9 
not be supported. 
The effect of glyceryl guaiacolate on the central nervous 
system is the reason for its inclusion in the armamentarium of 
the veterinary anesthesiologist. Its primary effect is to 
block transmission of nerve impulses through the spinal cord, 
brain stem and subcortical areas of the brain, resulting in a 
profound muscular relaxation. 
Its effects on the nervous system have been shown to be 
central, rather than peripheral as in the case of the myo-neural 
junction blocking agents such as curare or succinylcholine 
hl . d (13, 24) c ori e In addition glyceryl guaiacolate produces a 
hypnotic and psychic effect mediated through a direct 
. . . (20, 26 , 29) 
depression of the cortical areas of the brain In 
humans this psychic effect is manifested as a feeling of 
tranquility which progresses to euphoria and, as the dose of 
solution is increased, an analgesic state( 9 , 26 • 29 • 43 ) is 
reached. Animal trials have also shown an analgesic effect 
when solutions of glyceryl guaiacolate are administered at 
. (29 31 54) appropriate dosage rates ' ' . 
Glyceryl guaiacolate has been administered to pregnant 
subjects, both human and animal, with no damage to the fetus 
being observed. Gynecologists have attributed this phenome-
non to the inability of glyceryl guaiacolate to pass the 
10 
. (20, 54) 
placental barrier . 
The metabolism and detoxification of glyceryl guaiacolate 
have been studied in man, the dog and the horse. It has been 
shown that the intact molecule is the active principle in the 
d 
( 34) 
og . Glyceryl guaiacolate exhibits no hepatotoxic 
properties and is apparently metabolized in the liver(
7
) . In 
the horse, plasma levels in excess of 238 ug . / ml. were 
necessary to produce complete muscle relaxation, with the 
. h d. h . 1 ( 12 ) exception of t e iap ragmatic muscu ature . The time 
required for plasma levels to be halved ranged from 55-85 
minutes. At plasma levels of approximately 154 ug . / ml . the 
horses were able to stand and plasma levels of 150 ug. / ml. 
produced no visible effects in the horse . The metabolites of 
glyceryl guaiacolate are excreted by the kidney in the form 
of catechol and polar metabolites of catechol (l2 ). These 
urinary metabolites could be the active factors in the 
d t ' f ' d • ( 12 I 1 7) pro uc ion o toxic over ose to glyceryl guaiacolate 
Catechol toxicity is characterized by tetany, convulsLons, 
hypotension, deep coma, apnea and death due to respiratory 
failure. These signs are also characteristic of those 
observed with toxic overdose of glyceryl guaiacolate . 
The incidental pharmacological properties of glyceryl 
guaiacolate neither aid nor hinder anesthesia. It has been 
11 
shown to have slight bacteriostatic, antipyretic and anti-
. . t. ( 9) phlogistic proper ies . 
Clinical Considerations 
Glyceryl guaiacolate is not commercially available in 
the United States in preparations suitable for intravenous 
administration . Investigators must therefore make up their 
f 1 t
. (22, 28, 33, 39, 47) 
own orrnu a ions . The usual concentration 
administered is 5% glyceryl guaiacolate either in water, 
saline or 5% glucose solution. One investigator(
47
) has 
utilized combinations of glyceryl guaiacolate and pentothal 
d . h'l h (22, 38) . . so ium w i e ot ers have used glyceryl guaiacolate in 
combination with thiamyl sodium or thiopental sodium. The 
barbiturate concentrations reported were approximately 0.2%. 
In Europe commercial preparations of glyceryl guaiacolate 
are available. One preparation which has been utilized 
extensively in both human and animal subjects(l , ll, 20 • 53 • 
54 ) . 5 '1 1 . f 1 . is a ~ so ution o g yceryl guaiacolate in 5% levulose 
1 
(My 301 ) marketed in 20 ml. amp0ules. Other preparations 
available are, 20% glyceryl guaiacolate in 5% levulose (My 301 
1 
Brunnengraber, Lubeck, W. Germany. 
12 
forte
1
) supplied in 10 ml. ampoules 20% solution in 5% 
dextrose (G.G.G. 2 ) in 500 ml. bottles, and 5% glyceryl guaia-
colate in isostonic saline (Myocain A
3
) in 
(54) 
20 ml. ampoules . 
Preparations in oral form are available but are not used as 
frequently as the intravenous preparations. 
The early investigations on the use of glyceryl guaia-
colate as a muscle relaxant were carried out using laboratory 
. 1 (24, 25) 
anima s . Studies utilizing white mice indicated the 
ability of glyceryl guaiacolate to antagonize the toxic 
effects of strychnine. In rabbits doses of 100 mg. /kg. were 
sufficient to produce a complete paralysis of 15-20 minutes 
duration. With doses of 200 mg. / kg. respiration was not 
appreciable impaired in the rabbit. 
The use of glyceryl guaiacolate in the small species of 
animal such as the dog and cat has been rather limited. The 
usual practice in cats is to premedicate the subject with 
atropine ( .2-.4 ml. / kg.) and induce the anesthetic state using 
1 
Brunnengraber, Lubeck, W. Germany. 
2 . 
Grunau, Berlin, Germany. 
3 1 . . Ho zinger, Vienna, Austria. 
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a barbiturate anesthetic. One author(G) then administered a 
200/o glyceryl guaiacolate solution intravenously , empirically 
using the degree of muscle relaxation and relief from pain 
as the indicators for the dosage necessary . Good clinical 
results were claimed for this method. 
( 45) 
Another author 
administered 50% solutions of glyceryl guaiacolate by either 
intravenous, intraperitoneal or interosseus routes . The dose 
again was metered by the relaxation and analgesic state 
desired but in this case never exceeded 10 ml. of the 50% 
solution. 
The effective dose for use in the dog has been stated to 
(17) 
be 200 mg./kg. . The lethal dose in the dog is approximate-
ly 700 mg./kg. 
A 20% solution of glyceryl guaiacolate is suitable for 
use l.·n . (21) pigs . The administration of 5 ml. / 10 kg. body-
weight intravenously caused the animal to assume a recumbent 
position. A total dose of 8-9 ml. / 10 kg. was necessary to 
produce a completely relaxed state. The influence of glyceryl 
guaiacolate on heart rate, respiration and body temperature 
was found to be minimal in the pig and no adverse physiological 
alterations could be observed after administration. 
The administration of glyceryl guaiacolate solution to 
14 
the small ruminant species has been carried out with few 
( 20) adverse effects . A 5% solution of glyceryl guaiacolate 
in 5% levulose was utilized as the preparation of choice. 
The administration intravenously of 120-220 ml. of this 
solution was necessary to cause the animal to assume 
recurnbency. The muscle relaxant effect was found to last 
12-15 minutes. The author was able to extend this time by 
the administration of additional quantities of solution by a 
slow drip infusion technique. The solution was administered 
at the rate of 100 drops/ minute. By this method the subjects 
were retained in the recumbent position for periods of one 
hour without adverse physiological changes, either during or 
after the administration period . No disturbances in rumen 
motility we re observed. The only undesirable side effect 
observed was increased salivation during the relaxant period. 
The author recommended the use of the central acting analeptics 
to counteract the relaxant effect of glyceryl guaiacolate in 
the small ruminant species. 
In the larger ruminant species, glyceryl guaiacolate has 
been used alone in the standard concentrations(52 ) , in 
combination with tranquilizers and thiopental sodium(l9 ) and 
. rnb' t' . h . (47) in co ina ion wit pentothal sodium . The same 
observations have been made in large ruminants as in the small-
15 
er ruminant species. The standard ocular reflexes were of 
little use in determining the depth of anesthesia in the ... ~o\,. 
. . . ( 4 7) 
during glyceryl guaiacolate administration . Instead, as 
the relaxation becomes more profound the eye moves in a 
counterclockwise rotation, first dorsally, then ventrally 
and finally returns to center position when the subject is 
under the full influence of the solution. During recovery 
the sequence of eye movements was reversed. The dosage 
rate necessary for recumbency to be assumed is stated to be 
1 ml./lb. of body weight of a 5% solution or 4-5 g . /50 kg. of 
. (54) body weight • As in the small ruminants the action of 
glyceryl guaiacolate can be partially inhibited by the use 
of the central acting 
. ( 54) 
analeptics • 
Glyceryl guaiacolate has been evaluated clinically as a 
muscle relaxant for use in human subjects. In Europe the 
drug has been used extensively in the disciplines of surgery 
(1, 3, 7, 10, 11, 16, 29, 35, 50) 
and traumatology The 
;-::.:;:-.:lration most often used was a 5% glyceryl g•.:io.~~cc :....::..--:~ 
solution in 5% levulose. The method of administration used by 
(10, 11) 
one author was to premedicate the patient with the 
usual dosages of morphine and atropine. In one series of 
(10) 
trials , basal narcosis was initiated using barbiturates. 
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Muscle relaxation and deeper narcosis were achieved by the 
infusion of 20 ml. of the 5% solution of glyceryl guaiacolate . 
Good muscle relaxant effects were observed for 4-6 minutes 
using this method of administration . 
In another series of administrations by the same 
( 11) . 
author basal narcosis was maintained using low levels of 
ether inhalation . An excellent degree of muscle relaxation 
was observed using this technique. 
A study( 35 ) , in which inhalant anesthesia was used in 
conjunction with muscle relaxation by glyceryl guaiacolate 
infusion, revealed that a dosage rate of 80-120 ml . of the 
5% solution to an adult human, markedly potentiated and 
lowered the dose of inhalant necessary. 
( 7) 
Another author commented on the apparent compatibility 
with, and potentiation of , ether - nitrous oxide narcosis by 
glyceryl guaiacolate. 
When pentothal ~ nitrous oxide anesthesia was used to 
provide basal narcosis(l) the dose of 5% glyceryl guaiacolate 
necessary to produce good muscle relaxation ranged from 
20-82 ml. In this study repeated doses were administered 
with no evidence of cumulative effect . 
In one series of clinical trials( 50) the commercially 
17 
available 20% solution of glyceryl guaiacolate in 5% levulose 
was evaluated . The muscle relaxant effect was found to be 
more rapid and longer acting than with the 5% solutions. No 
hemolysis or intravasal damage was observed . Four to six 
ml. of the 20% solution were required to produce muscle 
relaxation in the adult human. A total dose of 30 ml. was 
administered in this study, achieving 72 minutes of muscle 
relaxation with no adverse effects being observed clinically. 
Infusion of glyceryl guaiacolate solutions to relieve 
(5 1) 
the muscle spasms associated with tetanus and other 
spastic conditions have been successfu l in human patients. 
In the case of tetanus therapy , total doses as high as 73 . 2 
grams over an eight day period have been administered . A 
dose of 100 mg./lb./day has been administered with few side 
(8) 
effects and definite relaxant properties being observed . 
In a study to determine the ability of the muscle 
relaxant properties of glyceryl guaiacolate to eliminate 
post operative urinary retention , 10 ml . doses of a 5% 
solution were administered intravenously to 40 surgical 
patients(l
5
). The drug was effective in fifty- five percent 
of the patients. 
In cases of novocaine shock, 10-20 ml. doses of a 20% 
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glyceryl guaiacolate solution given intravenously, were 
found to relieve or eliminate the muscle cramps associated 
with this condition<
29>. 
The administration of glyceryl guaiacolate solutions 
has not been incriminated as causing habituation , addiction 
(29) 
or allergic responses in human subjects . 
In the horse glyceryl guaiacolate has been used in 
combination with many other preanesthetic and anesthetic 
agents. In Germany most investigators have premedicated the 
subject with a combination of an ataractic and an analgesic 
drug before the administration of the glyceryl guaiacolate 
solution< 4 • 42 • 53 ) This ataract io-analgesic combination 
has been termed a "lytic cocktail 11 <42 >. The dose of 5% 
solutions of glyceryl guaiacolate required to cause complete 
relaxation is stated to be .5-1 ml. / lb. administered 
rapidly intravenously( 4 , 53 ). This dose results in a period 
of profound relaxation of 5-15 minutes duration . As dosage 
rates of this magnitude abolish pain reflexes previously 
present an analgesic effect has been concluded for glyceryl 
guaiacolate in the horse< 43 ). 
The use of glyceryl guaiacolate in horses was introduced 
. (41) 
in the United States in 1965 . It was described as being 
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preceded by the "lytic cocktail" combination in common use in 
Germany. The preparation described was a 5% solution of 
glyceryl guaiacolate and a .2% solution of barbiturate in 
5% dextrose. 
(22, 38 , 39, 40) 
American investigators have 
since completed extensive clinical trials. The "lytic 
k 'l" . b . . (38, 39) . d f coc tai in use y some investigators consiste o 
atropine sulfate, promazine, and meperidine. Ten minutes 
after the administration of the lytic cocktail a 5% glyceryl 
guaiacolate and .2% thiopental-sodium solution was administered 
rapidly intravenously. The subject was described as falling 
gently after approximately .5 ml./lb. of this combination had 
been administered. A "blitz" or crash type induction was not 
observed. A total dose of 1 ml./lb. of body weight resulted 
(38) 
in excellent relaxation. In a study to determine what , if 
any , irritation would result from accidental perivascular 
injection of the glyceryl guaiacolate-thiopental mixture , 
25-50 cc. doses were given subcutaneously. Only a mild 
inflammation of surrounding tissue resulted . 
In a study in which a 5% glyceryl guaiacolate and . 2% 
th . 1 1 d' mb' . (22) iamy a so ium co ination was evaluated as an induction 
agent , this combination was found to be compatible with both 
20 
1 2 
methoxyflurane (Metofane) and halothane (Fluothane ) . The 
lethal dose of this combination was found to be three times 
the therapeutic dose. 
In studies comparing the effectiveness of glyceryl 
guaiacolate to that of succinylcholine chloride as induction 
. (28, 46) . 
agents for inhalation anesthesia , glyceryl guaiacolate 
was shown to have far less depressant action on cardio-
pulmonary function than did succinylch0line chloride. 
Succinylcholine chloride was extremely hypertensive while 
glyceryl guaiacolate exhibited a minimal physiological 
response(
2
S). Dosage rates of 160 mg. / kg . of 5% solution of 
glyceryl guaiacolate caused recumbency while causing only 
minor depression of mean arterial blood pressure and arterial 
. ( 46) . I 
oxygen tension . Eighty mg. kg. of glyceryl guaiacolate in 
combination with 3.5 mg./kg. of thiopental sodium was as 
effective in relaxant properties but caused more profound, 
though minor, changes in arterial blood pressure and oxygen 
tension. 
1 . 
Pitman-Moore Inc., Fort Washington, Pa. 
2 
Ayerst Laboratories Inc., New York, New York . 
21 
Solutions of glyceryl guaiacolate have been shown to be 
ff . . h f . h h ( 
17 ) e ective in t e treatment o tetanus in t e orse . One 
hundred mg./kg . doses of glyceryl guaiacolate administered 
as needed through the course of treatment relieved the 
muscle spasms associated with tetanus. Glyceryl guaiacolate 
was shown to have a cumulative effect when used in this 
manner. 
22 
MATERIALS AND METHODS 
Laboratory Animals 
Thirty horses of various breeds were used in the 
investigation. The horses were selected randomly from those 
presented to the Veterinary Clinic at Iowa State University 
for surgical procedures requiring general anesthesia. The 
horses were characterized as to breed, sex, age, and weight, 
and this information was recorded. The weight of each horse 
was obtained by estimation. The medical histories of the 
horses were variable and were not recorded. 
Glyceryl Guaiacolate Solution 
The solution evaluated in the study was a glyceryl 
guaiacolate-thiamylal sodium combination prepared by 
dissolving fifty grams of sterile glyceryl guaiacolate 
1 
powder (Gecolate ) and two grams of thiamylal sodium 
(Surital
2
) in one liter of sterile water. It was necessary to 
warm the preparation to facilitate the formation of the 
1
summit Hill Labs, Summit, New Jersey. 
2 k . Pare Davis and Co., Detroit, Michigan. 
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solution. A warm water bath was utilized for this purpose . 
The glyceryl guaiacolate-thiamylal sodium mixture was 
prepared immediately prior to each administration , so that 
fresh solutions were administered in every instance . 
Sampling Technique 
A technique was devised to obtain anaerobically drawn 
arterial blood samples for the blood gas determinations . 
The carotid artery was chosen as the most accessible site 
when the subject was either standing or recumbent. The 
jugular vein was raised and its dorsal border was marked as 
the dorsal landmark at which the needle puncture would be 
made. At this landmark , in the ventral one-third of the 
jugular furrow, (Figure 1), a sterile twenty gauge , one and 
one- half inch needle was inserted through the skin . The 
needle was directed medially and ventrally , medial to the 
jugular vein , until the pulsations of the carotid artery 
could be felt with the tip of the needle. The needle was 
then inserted into the lumen of the carotid artery (Figure 2) . 
The sample was collected in a two and one- half milli liter 
disposable syringe. The syringe was wetted with heparin 
24 
sodium (Heparin1) prior to its use and all air was evacuated 
leaving a drop of heparin sodium in the tip of the syringe 
to maintain anaerobic conditions. Immediately after the 
syringe was filled and withdrawn from the subject , the tip 
of the needle was closed by insertion into a rubber stopper 
and the sample was placed in an ice bath (Figure 3) . The 
sample was then transported to the clinical pathology 
laboratory as soon as possible and blood gas and blood pH 
determination were done immediately. 
Formation of a hematoma in the carotid sheath or 
surrounding structures was prevented by either the 
application of a compression bandage or finger pressure over 
the area of the carotid puncture (Figure 4) . 
The venous blood samples required for the remainder of 
the hematological parameters investigated were collected by 
jugular puncture into commercially available, ethylene diamine 
tetracetic acid vacum tubes (Vacutainer2) . 
1
1000 units 1ml. -- Upjohn Co., Kalamazoo, Michigan. 
2 . k" Becton-Die inson, Columbus, Nebraska. 
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Administration and Sampling Procedure 
An arterial blood sample and a venous blood sample were 
collected at four time intervals on each subject. The first 
set of samples was taken while the horse was standing quietly 
in a box stall and prior to the administration of any pre-
anesthetic or anesthetic preparation. This sample was the 
"normal" control for purposes of statistical analysis. 
The subject was then administered . 5 mg./kg. of promazine 
(Sparine
1
) to induce a state of ataraxia. A period of time 
ranging from ten to thirty minutes was allowed to pass so that 
the full effect of the promazine developed. A second set 
of samples was then collected with the horse still in a 
quiet stall. These were the post-tranquilization samples . 
The horse was then led to a padded area suitable for 
casting and the intravenous infusion of the g lyceryl 
guaiacolate-thiamylal sodium solution was begun . The solution 
was administered as rapidly as possible through a twelve 
gauge needle (Figure 5) . The dosage necessary to cause the 
horse to assume a recumbent position was noted and recorded. 
1 
wyeth Laboratories Inc., Philadelphia, Pennsylvania. 
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The post-infusion blood samples were collected as soon as 
possible after the horse was recumbent. 
In one group of 4 horses the infusion was stopped at 
this time and a mouth speculum was applied. An endotracheal 
tube of appropriate size was inserted and connected to a 
closed circuit circle system anesthetic machine (I Fraser 
1 
Sweatman VML ) . The presence or absence of laryngeal and 
pharyngeal reflexes and the ease with which the endotracheal 
tube could be passed were noted and recorded. The horse was 
then subjected to a period of general anesthesia with halo-
thane during which the surgical procedure required was 
performed. 
In another group of 26 horses the infusion of the 
glyceryl guaiacolate-thiamylal sodium solution was continued 
until a state of surgical anesthesia was attained . The 
dosage of the solution necessary to achieve a state of 
surgical anesthesia was noted and recorded . Numerous 
surgical and diagnostic procedures were performed on this 
group of horses. Surgical anesthesia was maintained for 
1 
Fraser Sweatman Inc., Lancaster, New York. 
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varying periods of time in this group of horses by a slow 
infusion technique in which monitored doses of the glyceryl 
guaiacolate-thiamylal sodium mixture were administered a s 
needed to maintain an absence of pain responses. The amount 
of time surgical anesthesia was maintained and the total 
dose of solution necessary to do so were noted and recor ded . 
The horses in both groups were allowed to recover from 
the effects of either the glyceryl guaiacolate-thiamylal 
sodium mixture or the halothane , and the time required for 
the animal to regain its feet was noted and recorded. 
The fourth set of blood samples collected were the 
recovery samples. The thirty horses investigated were 
divided into two groups for the purpose of the collection of 
the recovery samples. In the first group of 23 horses the 
recovery blood samples were drawn immediately after the 
subject had regained its feet and before it was returned to 
its stall. In the second group of 7 horses the subject was 
returned to its stall upon regaining its feet and the 
recovery samples were collected twenty four hours later . 
Clinical Pathological Determinations 
The four arterial blood samples collected from each 
subject were subjected to oxygen partial pressure , carbon 
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dioxide partial pressure and blood pH determination in the 
clinical pathology laboratory at Iowa State University 
Veterinary Clinic. The instrument used was a micro-sample 
blood gas analyzer and glass pH electrode apparatus (Model 
113 - s2 1 ) (Figure 6) . The blood gas partial pressures were 
corrected for the local barometric pressure factor and 
recorded using m.m. Hg. as the unit of measure. The blood pH 
values were read directly from the apparatus and recorded. 
The venous samples were divided into appro?riate 
quantities and various hematological parameters were 
determined. Blood glucose determination was carried out 
utilizing a modified glucose oxidase reaction and colorimetric 
methods (Unimeter 250
2
) . The data was recorded in milligrams 
percent. 
Hemoglobin determination was done utilizing the 
cyanmethemoglobin method and spectrophotometric apparatus 
3 (Coleman Jr. Model 620 Spectrophotometer ) . Values thus 
1 . 
Instrumentation Laboratories Inc., Lexington, Massachu-
setts. 
2 . d . Bio ynamics Inc., Indianapolis, Indiana. 
3 
Coleman Instrument Corp., Maywood, Illinois. 
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obtained were recorded in grams percent. 
The packed cell volume of each sample was determined by 
the microhematocrit method (International micro-capillary 
Centrituge and Reader1 ) and was recorded in units o f percent. 
Erythrocyte counts were done using isotonic saline as 
the diluent in a 1:50,000 dilution. The counts were made 
2 
using an electronic particle counter (Coulter Counter ) . The 
data obtained was recorded in cells/ m.m.
3
. 
Leukocyte counts were done using isotonic saline in a 
1:500 dilution. The erythrocytes were lysed using a 
commercially available lysing agent (Zap-Isoton
3
) . Cell 
counts were done by means of the electronic particle counter 
and recorded in cells/ m.m. 3 . 
Blood smears were made, stained using Wright's stain , 
and differential leukocyte counts were done. Differential 
counts were recorded in units of percent. 
1 . 
International Equipment Co., Boston, Massachusetts. 
2 
Coulter Electronics Inc., Hialeah, Florida. 
3 
Coulter Electronics Inc., Hialeah, Florida . 
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Statistical Analysis 
The data was collected, grouped and coded for computer 
analysis . Descriptive analysis and correlation analysis 
using the correlated T test were done by the Iowa State 
University Computation Center. 
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RESULTS 
Clinical Evaluation 
The physical properties of the g l yceryl guaiacol ate-
thiamylal sodium formulation prepared for this study were 
found to be adequate. The solution was easily prepared and 
remained stable for a period of approximately forty eight 
hours without flocculation occurring. Although solutions 
used in this investigation were prepared fresh before each 
administration , solutions up to forty eight h ours old have 
been utilized without special preparation or adverse 
consequences. 
Rapid administration of the glyceryl guaiacolate-
thiamylal sodium solution proved to be a necessary pre-
requisite for a smooth and uneventful induction phase . It 
was found the faster the infusion could be carried out the 
more rapid was the onset of the muscle relaxation and the 
less apprehension was observed in the subject. In those few 
administrations in which difficulty was encountered in the 
infusion process, due to improper jugular puncture or 
intractability of the patient , the subject seemed to be more 
aware of the onset of the muscular relaxation and was more 
inclined to resist the restraint applied. The induction 
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phase, even when difficulties were encountered , was 
routinely smooth and uneventful. The action of the solution 
was so rapid and insidious that even the most intractable 
horses exhibited a minimum of apprehension . 
The mean dosage rate necessary to produce a degree of 
muscular relaxation resulting in sternal recumbency was 
65 mg . /kg. of glyceryl guaiacolate and 2 . 6 mg./kg . of 
thiamylal sodium (1 , 3 ml. / kg. of a 5% glyceryl guaiacolate-
. 2% thiamylal sodium solution). At this dosage rate the 
pharmacological effects were profound enough to permit 
manipulation of the extremities and repositioning of the 
animal. None of the thirty horses in this study exhib i ted 
signs of respiratory distress or apnea during the induction 
phase . The horses did not object to the carotid puncture 
which was necessary to collect the arterial samples although 
pain reflexes were still present at this dosage rate . In 
those horses which were to be subjected to general anesthesia 
with a closed circuit circle system halothane unit this dose 
resulted in sufficient depression of the pharyngeal and 
laryngeal reflexes to allow endotracheal intubat·ion. The 
duration of the anesthetic state was sufficient to allow a 
smooth transition to the halothane unit and resulted in a 
short and uneventful halothane induction . Respiration 
33 
continued when the subject was connected to the halothane 
circuit so that voluntary apnea was not a problem . 
In those 23 horses in which the glyceryl guaiacolate-
thiarnylal sodium solution was used as the only anesthetic a 
mean dosage rate of 115 mg. / kg. glyceryl guaiacolate and 
4.6 mg./kg. of thiarnylal sodium (2.3 ml. / kg. of the 5% 
glyceryl guaiacolate-.2% thiarnylal sodium solution) produced 
a state of surgical anesthesia of 25 minutes duration. The 
anesthetic state produced was characterized by profound 
muscular relaxation, immobility, and absence of previously 
present pain reflexes. The ocular reflexes historically 
utilized as indicators of anesthetic depth were of limited 
value. Nystagmus was usually not observed during the induction 
or anesthetic periods. Palpebral and corneal reflexes were 
routinely present at anesthetic dosage rates but were of 
limited value in evaluating anesthetic plane. Cardiac 
function was unef fected. Cardiac rates while under the 
influence of glyceryl guaiacolate-thiarnylal sodium 
anesthesia were in the range of 40-60 beats/ min. No 
pathological abnormalities were observed in those horses 
which were monitored electrocardiographically. Respiratory 
function was altered in that during the period of surgical 
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anesthesia, respiration was almost entirely diaphragmatic. 
Respiratory rates ranged from 4-12 breaths/ min . No attempt 
was made to monitor respiratory volume. None of the horses 
in which the glyceryl guaiacolate-thiamylal sodium solution 
was used as the only anesthetic agent exhibited apnea. 
The longest period of time that a horse was maintained 
in a state of anesthesia using glyceryl guaiacolate-thiamylal 
sodium solution as the only anesthetic agent was ninety 
minutes. The total dose required for this horse was 222 
mg./kg. of glyceryl guaiacolate and 9 mg./kg. of thiamylal 
sodium (4.4 ml./kg. of a 5% glyceryl guaiacolate-.2% thiamylal 
sodium solution) administered by a slow infusion monitored 
dos e technique. Cardiac and respiratory function remained 
uneffected during the anesthetic procedure. 
The period required for recovery in those horses in 
which general anesthesia was maintained with halothane 
averaged 39 minutes. Recovery was smooth and characteristic 
of a typical recovery from inhalation anesthesia. These 
horses did not appear to have any residual pharmacological 
effect from the glyceryl guaiacolate-thiamylal sodium infusion . 
In those horses in which glyceryl guaiacolate-thiamylal 
sodium solution was used as the only anesthetic agent recovery 
was routinely smooth. The mean time required for recovery in 
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this group of horses was 25 minutes . The horses rema ined 
quiet during the recovery period with only minor evidence of 
apprehension observed. The pharmacological effects of the 
infusion appeared to disappear from the higher central 
nervous centers first. Muscular function returned first to 
the head and forequarters. The laryngeal and pharyngeal 
reflexes became functional early in the recovery per i od. 
The hindquarters were the last area to regain muscular tone. 
If left alone in a quiet recovery area the horses assumed 
sternal recumbency and voluntarily remained in that position 
for a few minutes. They then stood with very little 
difficulty. Some muscular weakness and ataxia were 
exhibited just after standing. 
Hematological Evaluation 
The mean values for the blood cell determinations are 
listed in Table 1 . The values obtained by analysis of the 
control sample were all within the published normal range for 
blood cell determination of the horse. Administration of the 
ataractic had no appreciable effect on these values . Infusion 
of the glyceryl guaiacolate-thiamylal sodium solution had no 
significant effect on the mean blood cell counts of the 
thirty horses investigated. The recovery sample did indicate 
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an increase in the mean number of leukocytes and a 
corresponding neutrophilia and lymphopenia as shown by the 
differential leukocyte count. This leukocytosis was more 
apparent in those horses in which 24 hours were allowed to 
elapse before the recovery sample was collected (Table 4) . 
The mean value for blood glucose level of the control 
samples was 101.1 mg. % (Table 2). Administration of the 
ataractic had no appreciable effect on blood glucose level . 
Infusion of the glyceryl guaiacolate-thiamylal sodium 
solution had no predictable effect on the blood glucose 
level of the horses in this study. 'rhe mean value for blood 
glucose of the post infusion sample was 103 . 3 mg. %. The 
mean value for blood glucose of the recovery sample was 
108 . 5 mg.% . Although this was slightly higher than the 
other three samples it is not a significant increase in 
circulating blood glucose. 
The mean values of the blood gas determinations of all 
subjects are listed in Table 3. The blood pH did not change 
significantly with either the administration of the ataractic 
or the glyceryl guaiacolate-thiamylal sodium solution . The 
mean value for partial pressure of oxygen of the control 
sample was 94.3 mm. Hg. (Table 3). Administration of the 
ataractic resulted in a slight decrease in mean partial 
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pressure of oxygen. Infusion of glyceryl gua iacolate-
thiamylal sodium solution resulted in a further decrease so 
that the mean value of oxygen partial pressure was 84.3 mm . 
Hg. for the post infusion sample. The partial pressure of 
oxygen increased during the recovery phase so that the mean 
value for the recovery sample was 88.5 mm. Hg. Neither the 
administration of the ataractic or the glycery l guaiacolate-
thiamylal sodium solution had an effect on the carbon dioxide 
partial pressure. The mean value of carbon dioxide partial 
pressure was approximately 40 mm. Hg. in the post 
tranquilization, and post infusion sample as well as in the 
control and recovery sample. 
The effect of glyceryl guaiacolate-thiamylal sodium 
infusion on blood gas partial pressure is even more apparent 
if a comparison is made between those horses which received 
no extrinsic oxygen source and those which received oxygen via 
a closed circuit circle system anesthetic machine . The mean 
value for oxygen partial pressure of the post infusion sample 
in those horses receiving no extrinsic oxygen was 72.4 mm. Hg. 
(Table 6) . The mean value for partial pressure of oxygen of 
the post infusion sample in those horses which were connected 
to the anesthetic apparatus immediately on assuming sternal 
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recumbency was 162.8 mm. Hg. In both of these groups of 
horses the recovery sample indicated a return to the normal 
control value of oxygen partial pressure when the subject had 
recovered from the effects of the anesthetic agent. 
In those horses which received extrinsic oxygen via the 
anesthetic apparatus there was a significant increase in 
partial pressure of carbon dioxide in the post infusion 
sample. The mean value for carbon dioxide partial pressure 
in this group of horses was 45.9 mm. Hg. There was a 
corresponding decrease in blood pH in this group of horses 
(Table 6) . The collection of the recovery sample twenty 
four hours after clinical recovery had no predictable effect 
on the mean v alues of partial pressures of blood gas or 
blood pH (Table 5) . 
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DISCUSSION 
Clinical Evaluation 
The intravenous infusion of 5% glyceryl guaiacolate-
. 2% thiamylal sodium solution proved to be an effective and 
safe method for the induction and maintenance of anesthesia 
in the horse. 
The solution as formulated for this study had adequate 
physical properties. The glyceryl guaiacolate and thiamylal 
sodium were readily soluble at the concentrations utilized. 
The use of a warm water bath was necessary to attain the 
critical temperature for the preparation to go into solution 
but this was not a major problem. A shelf life of 
approximately 48 hours was observed after which time 
flocculation occurred. Although it was possible, by warming , 
to redissolve the formulation it was thought that some decrease 
in efficacy resulted and thus it is recommended that only 
fresh solutions be used. 
The concentration of glyceryl guaiacolate-thiamylal 
sodium solution evaluated in this study proved to be an 
excellent formulation for clinical use. The inclusion of an 
ultra-short acting barbiturate in the formulation is 
recommended. There appears to be a synergistic effect 
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between the glyceryl guaiacolate and the barbiturate which 
reduces the dosage of each required to attain a desired depth 
of anesthesia. Concentrations and combinations other than 
the one investigated have been recommended by other 
h 
(38, 40, 41) 
aut ors for use in the horse. The 5% glyceryl 
guaiacolate-.2% thiamylal sodium aqueous solution was 
excellent in that it was highly efficacious, did not cause 
intravenous hemolysis or other toxic side effects , and did 
not require the infusion of awkwardly large amounts of 
solution. 
Rapid infusion of the solution was found to be necessary 
for a smooth induction. If the infusion rate was sufficiently 
slow the subject became very ataxic and apprehensive before 
the muscular relaxation became sufficiently profound to cause 
sternal recumbency. An adequate rate of infusion could be 
attained through the use of a 12 gauge intravenous needle. 
The rapid metabolism and short plasma half-life of glyceryl 
guaiacolate are probably responsible for this phenomenon. 
Rapid infusion of the solution is necessary to achieve plasma 
levels of a sufficient magnitude to cause the desired 
pharmacological effect before metabolic detoxification can 
reduce plasma concentration to an ineffective level. 
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Induction of anesthesia was routinely smooth , even when 
difficulties with the infusion were encountered. The rapid 
onset of action and insidious nature of the solution were 
such that even the most intractable subjects could be cast 
with a minimum of danger to the horse or the operator. Before 
the animal was aware of the loss of function, the muscular 
relaxation was so profound that only ineffectual resistance 
could be manifested. The blitz or crash type induction 
observed with the use of the peripheral neuro- muscular 
agents or barbiturate anesthetics alone was not observed . 
The subject appeared to succumb to a profound muscular 
relaxation and sank gently into sternal recumbency. A 
minimum of physical restraint was necessary so that three 
operators, one administering the infusion, one supporting the 
head and one supporting the hind quarters, could cast most 
subjects. If extremely gentle handling was necessary, as in 
the case of casting an animal with a fracture of a limb or a 
pregnant female , then physical support was applied and the 
animal was lowered to the floor of the casting area after the 
maximum pharmacologic effects had been achieved . 
The 5% glyceryl guaiacolate-.2% thiamylal sodium 
solution was administered to several pregnant females in 
various stages of pregnancy with no adverse effects being 
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observed. The observation lends support to those 
investigations in which it has been stated that glyceryl 
. (20, 54) 
guaiacolate does not pass the placental barrier . 
This could be an indication for the use of glyceryl 
guaiacolate solutions for the induction and maintenance of 
anesthesia for cesarean section. 
Endotracheal intubation is recognized as an essential 
technique for the maintenance of a patent airway when 
inhalation anesthetics are administered to the horse. In 
this respect glyceryl guaiacolate-thiamylal sodium infusion 
is an excellent induction method for use with inhalant 
anesthetics, as dosages which cause sternal recumbency to be 
assumed also depress pharyngeal and laryngeal reflexes 
sufficiently to allow endotracheal intubation . 
Glyceryl guaiacolate-thiamylal sodium solution was 
clinically compatible with halothane. The duration of action 
of the glyceryl guaiacolate-thiamylal sodium solution was 
sufficient to allow a smooth transition to the closed circuit 
circle system halothane unit. None of the horses in which 
anesthesia was induced using glyceryl guaiacolate-thiamylal 
sodium infusion exhibited apnea so that the transition to the 
halothane unit was very smooth. The rapid metabolic 
detoxification of the glyceryl guaiacolate-thiamylal sodium 
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solution is an excellent feature in that most procedures 
requiring general anesthesia with halothane are of sufficient 
length so that the plasma concentration of glyceryl 
guaiacolate has decreased to ineffective levels during the 
time the subject is under the influence of halothane . The 
horse is therefore able to recover from the inhalant 
anesthesia without residual action by the glyceryl 
guaiacolate-thiamylal sodium solution . 
The use of glyceryl guaiacolate-thiamylal sodium infusion 
as the exclusive anesthetic agent in procedures requiring a 
short period of surgical anesthesia is recommended. The 
anesthetic state produced by the infusion of glyceryl 
guaiacolate-thiamylal sodium solution is characterized by a 
profound muscular relaxation and analgesia . The state of 
immobility and muscular relaxation allows repositioning and 
manipulation of the horses legs for diagnostic procedures 
such as radiographic examination. The muscular relaxation 
necessary to allow closed reduction and cast application 
to leg fractures in the horse is easily achieved by the 
infusion of a glyceryl guaiacolate-thiamylal sodium solution. 
As very little apprehension is exhibited by the subject 
during the recovery phase there is little danger of damage 
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to the plaster cast or disruption of the fractured bone ends 
due to panic or struggling. 
The degree of analgesia produced by glyceryl 
guaiacolate-thiamylal sodium infusion is not as profound as 
can be produced by other anesthetic agents. It is profound 
enough, however, to allow surgical procedures which do not 
require an extreme depth of anesthesia but do require a 
marked muscular relaxation. The analgesic properties 
coupled with the profound muscular relaxation make glyceryl 
guaiacolate-thiamylal sodium infusion an excellent agent for 
use in such procedures as castration, cryptorchid castration, 
and umbilical herniorraphy. 
During the course of the investigation glyceryl 
guaiacolate-thiamylal sodium infusion was used as the only 
anesthetic agent in many other short procedures such as 
posterior digital neurectomy, ventriculotomy, excision of 
benign tumors and repair of lacerations. In those procedures 
which required a longer period of anesthesia glyceryl 
guaiacolate-thiamylal sodium solution was administered by a 
slow infusion monitored dose technique over an extended 
period of time. Mete r ed quantities were administered as 
needed to maintain a state of surgical anesthesia characterized 
by profound muscular relaxation, absence of peripheral pain 
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response, and intact ocular reflexes. 
The classical ocular signs of anesthetic depth were of 
limited value as pain responses were sometimes present when 
nystagmus was absent and the palpebral reflex was depressed. 
It was more reliable to gauge the dosage rate necessary 
based on the degree of muscular relaxation , absence of pain 
response and character and rate of respiration . Respiration 
was altered in that it was almost entirely diaphragmatic 
during the period of surgical anesthesia. This can be 
explained by the predilection of glyceryl guaiacolate to 
abolish nerve transmission in internuncial neurons supplying 
peripheral musculature at a much lower dosage rate than is 
necessary to obtund function of neurons supplying the 
diaphragmatic musculature. 
Respiratory rate and volume were not altered sufficiently 
to cause adverse clinical manifestations. 
The infusion of glyceryl guaiacolate-thiamylal sodium 
solution by the monitored dose technique prolongs the period 
of surgical anesthesia much longer than the dosage required 
would be assumed to do. 
This phenomenon can be explained by the cumulative 
effect of both glyceryl guaiacolate and thiamylal sodium . 
The deposition of thiamylal sodium in body lipids and its 
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subsequent slow release is a well known phenomenon. The 
mechanism of action of the cumulative effect of glyceryl 
(17) 
guaiacolate is not k n own but is stated to occu r • 
In those horses which were administered glyceryl 
guaiacolate-thiamylal sodium solution by the mon itored dose 
technique , doubling the total dose more than quadrupl ed the 
total anesthetic time . The longer the period of anesthesia 
maintained, the longer was the time required for recovery . 
This may be a function of the thiamylal sodium component of 
the solution rather than the glyceryl guaiacolate but could 
also support the claims in the literature of a cumulative 
effect for glyceryl guaiacolate . 
In the course of one administration of the glyceryl 
guaiacolate-thiamylal sodium solut ion a small qeantity was 
inadvertently injected perivascularly. This resulted in a 
local soft tissue reaction characterized by heat , swelling , and 
edema. Treatment with intravenous phenylbutazone 
(Butazolidine
1
) and hydrotherapy was successful in 
alleviating the local tissue reaction . . . . ( 38) In one i nvestigation 
1 
Jensen- Salsbery Laboratories , Kansas City, Missouri . 
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in which 25-50 ml. doses of glyceryl guaiacolate- thiopental 
sodium solution were injected subcutaneously only a mild 
inflammation of surrounding tissue resulted . 
The local reaction resulting from accident al perivascular 
injection may be due to the barbiturate component of the 
solution. It should not be assumed, however , that perivascular 
injection of glyceryl guaiacolate-thiamylal sodium solutions 
are of little consequence . Glyceryl guaiacolate in the proper 
concentration may by itself be capable of producing a local 
tissue reaction resulting in edema and the formation of a 
sterile abscess. Care should be taken that glyceryl 
guaiacolate-thiamylal sodium solutions not be accidentally 
administered perivascularly. 
Hematological Evaluation 
The infusion of a 5% glyceryl-guaiacolate-.2% thiamylal 
sodium solution intravenously was shown to have no acute 
adverse effect on the blood cell components of the horses 
investigated . There was no significant alteration in 
hemoglobin, erythrocyte count or packed cell volume , nor was 
there a consistent degree of hemolysis observed grossly in 
the post infusion samples. The use of a 5% concentration of 
glyceryl guaiacolate would appear to alleviate the 
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intravenous hemolysis which occurs with the intravenous 
administration of more concentrated glyceryl guaiacolate 
solutions. 
The leukocytosis that was observed in the recovery 
sample was not statistically significant although it was 
a constant observation. The neutrophilia and lymphopenia 
observed were significant (P< .05). When the recovery 
sample was collected 24 hours after clinical recovery the 
l eukocytosis was more pronounced than if the recovery 
sample was collected as soon as the subject assumed a 
standing position. This phenomenon was probably the result 
of the subject's normal response to the stress of the 
anesthetic and surgical procedure performed. 
Infusion of the glyceryl guaiacolate-thiamylal sodium 
solution had no significant effect on circulating blood 
glucose. The inclusion of glucose in the solution to be 
administered would therefore not be necessary as a means of 
maintaining blood glucose levels on the anesthetic subjects. 
The inclusion of 5% glucose in the formulation has been 
advocated as a method of decreasing the incidence of 
intravenous hernolysis resulting from the intravenous 
administration of glyceryl guaiacolate solutions. The 
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results of this study indicate that the inclusion of 
glucose in the formulation is not necessary as long as 
solutions of 5% glyceryl guaiacolate o r l e ss are 
administered. If concentrations greater than 5% glyce r y l 
guaiacolate are administered the inclusion of 5% gluco s e 
in the formulation is recommended . 
The decrease in oxygen partial pressure observed 
immediately after administration of the glyceryl guaiacolate-
thiamylal sodium s olution wa s a consistent and significant 
(P < . 10) observation. This phenomenon was the r e sult of the 
decreased respiratory capabili t y of the subject . The 
g lyceryl guaia colate thiamylal sodium solution effectively 
blocked transmission in internuncial n e urons responsible fo r 
innervation of the intercostal and abdominal musculature . 
Paralysis of these muscles effectively decreased the 
f 
respiratory capability of the subject. The fact that t h e 
animals were in a laterally recumbent position when t h e 
post infusion samples were collected may have contributed to 
this decrease in respiratory function. This is doubtful , 
however, as the post infusion samples were collected within a 
very few minutes of the time lateral recumbency was assumed , 
limiting the effect of the venous conge stion , grav itational 
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forces, and the venous to arterial shunt that occurs in the 
dependent lung when anesthetized horses are maintained in 
lateral recumbency for long periods of time. 
Though the decrease in arterial partial pressure of 
oxygen was consistent and significant it was not suf-
f iciently high to cause manifestation of clinical signs of 
hypoxia. Respiratory rate and volume remained constant 
throughout the anesthetic procedure though respiration was 
entirely diaphragmatic. The administration of oxygen via a 
closed circuit circle system anesthetic apparatus 
effectively increased the arterial oxygen partial pressure 
in horses anesthetized with glyceryl guaiacolate-thiamylal 
sodium solution. The use of glyceryl guaiacolate-thiamylal 
sodium infusion as an induction agent for general anesthesia 
with volatile anesthetics is highly recommended. 
Infusion of glyceryl guaiacolate-thiamylal sodium 
solution had no significant effect on arterial partial 
pressure of carbon dioxide. The increase in carbon dioxide 
tension observed in the post infusion samples of those horses 
in which anesthesia was maintained using a closed circuit 
circle system anesthetic apparatus was the result of the 
inability of the carbon dioxide absorption apparatus to 
effectively remove the carbon dioxide from the expired air. 
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It is probable that no closed circuit anesthetic apparatus 
can be designed which is totally effective in the removal of 
carbon dioxide from the expired air. In accordance with 
other authors it is recommended that the carbon dioxide 
absorption apparatus not be depended upon and that whenever 
possible a semiclosed system be utilized. 
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SUMMARY AND CONCLUSIONS 
Thirty horses were administered a 5% glyceryl guaiacolate 
- .2% thiamylal sodium solution intravenously. Arterial and 
venous blood samples were collected prior to administration, 
immediately after administration, and upon full recovery from 
the anesthesia resulting from this infusion . Hemoglobin, 
packed cell volume , erythrocyte count, leukocyte count , 
differential leukocyte count and blood glucose determinations 
were performed on the venous blood samples. The arterial 
samples were subjected to blood gas partial pressure and pH 
determination. The values obtained were analyzed and the 
effect of the infusion was determined. 
The infusion of the glyceryl guaiacolate-thiamylal 
sodium solution had no significant effect on hemoglobin, 
packed cell volume , erythrocyte count, leukocyte count, 
differential leukocyte count or blood glucose value in the 
horses investigated. 
The glyceryl guaiacolate-thiamylal sodium infusion 
depressed the arterial partial pressure of oxygen due to its 
ability to block transmission in internuncial neurons 
supplying the intercostal and abdominal musculature. This 
depression was statistically significant but resulted in no 
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clinical manifestation of hypoxia in the horses studied . 
The glyceryl guaiacolate-thiamylal sodium solution exerted 
no influence on arterial partial pressure of carbon dioxide 
or blood pH. The depression of arterial partial pressure of 
oxygen was effectively counteracted by the administration 
of oxygen via a closed circuit circle system anesthetic 
apparatus. 
Infusion of the glyceryl guaiacolate-thiarnylal sodium 
solution was evaluated clinically as a method of general 
anesthesia in the horse. Infusion of a 5% glyceryl 
guaiacolate-.2% thiamylal sodium solution intravenously at 
a dosage rate of 2.3 ml. / kg. was found to produce 15- 25 
minutes of surgical anesthesia characterized by a smooth 
induction, a good degree of analgesia, profound muscular 
relaxation and a smooth and uneventful recovery . Infusion of 
additional amounts of the glyceryl guaiacolate-thiamylal 
sodium solution by a monitored dose technique was found'to 
effectively prolong the period of surgical anesthesia . Using 
glyceryl guaiacolate-thiamylal sodium solution as the only 
anesthetic agent such surgical procedures as umbilical 
herniorraphy , cryptorchid castration and repair of 
lacerations were performed. 
The use of a 5% glyceryl guaiacolate-.2% thiamylal 
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sodium solution as an agent for induction of anesthesia 
maintained with inhalant anesthetics was evaluated. Infusion 
of the glyceryl guaiacolate-thiarnylal solution produced a 
smooth induction, abolished the laryngeal and pharyneal 
reflexes allowing endotracheal intubation, and was 
compatible with halothane. 
Glyceryl guaiacolate was shown to be a valuable 
addition to the armamentariurn of drugs used in anesthesia of 
the horse. 
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Table 1. Mean values for hematological determinations 
of all subjects 
Parameter 
Hemoglobin 
gm. % 
Packed Cell 
Volume % 
Erythroc~te 
Count/ mm. 
Leukocyte
3 count/ mm. 
Differential 
Leukocyte 
Count % 
Segmented 
Neutrophils 
Non segmented 
Neutrophils 
Lymphocytes 
Eosinophils 
Monocytes 
Basophils 
Control 
Sample 
13.2 
36.6 
8.47 
mill. 
11,863 
50 
1 
44 
5 
1 
1 
Post 
Tranquilization 
Sample 
11. 5 
32.0 
7.79 
mill. 
10,387 
52 
l 
43 
4 
l 
1 
Post 
Infusion 
Sample 
11. 5 
32. 2 
7.85 
mill . 
10,156 
53 
1 
42 
4 
1 
l 
Recovery 
Sample 
11. 7 
32.4 
7.89 
mill. 
12, 2 30 
58 
2 
36 
4 
1 
l 
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Table 2. Mean values for blood glucose levels of all 
subjects 
Parameter 
Glucose 
mg .% 
Control 
Sample 
101. l 
Post 
Tranquilization 
Sample 
104.7 
Post 
Infusion 
Sample 
103.3 
Recovery 
Sample 
108.5 
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Table 3. Mean values of blood gas determination of 
all subjects 
Parameter 
pH 
02 partial 
pressure 
mm. Hg. 
co2 partial 
pressure 
mm. Hg. 
Control 
Sample 
7.43 
94.3 
40.0 
Post 
Tranquilization 
Sample 
7.43 
89.3 
40 . 1 
Post 
Infusion 
Sample 
7.42 
84.3 
40.3 
Recovery 
Sample 
7.43 
88 . 5 
39.4 
66 
Table 4. The effect of immediate versus 24 hour post 
recovery collection of recovery samples on 
hematological values 
Parameter 
Hemoglobin 
grrf/o 
Packed Cell 
Volume % 
Erythrocyte 
count/mm. 3 
Leukocyte 
count/mm. 3 
Differential 
Le ukocyte 
Count % 
Segmented 
Neutrophils 
Non segmented 
Neutrophils 
Lymphocytes 
Eosinophils 
Monocytes 
Basophils 
Recovery Sample 
collected immediately 
11. 5 
31.8 
7.88 
mill. 
11,974 
57 
2 
38 
3 
1 
1 
Recovery Sample 
collected 24 hours 
after recovery 
12.4 
34 . 3 
7.91 
mill. 
13,071 
61 
1 
33 
4 
1 
1 
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Table 5. The effect of immediate versus 24 hour post 
recovery collection of samples on blood pH 
and blood gas determination 
Parameter 
pH 
02 partial 
pressure 
mm. Hg. 
C02 partial 
pressure 
mm. Hg. 
Recovery Sample 
collected immediately 
7.42 
89.1 
38.9 
Recovery sample 
collected 24 hours 
after recovery 
7.44 
86.3 
40.9 
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Table 6 . The effect of oxygen administration by a 
closed circuit anesthetic apparatus on 
blood gas values 
Parameter No oxygen source Oxygen supplied 
Post infusion Recovery Post infusion Recovery 
sample sample sample sample 
pH 7 .43 7.43 7.33 7.43 
02 partial 72.4 88.2 162.8 90 .0 
pressure 
mm. Hg. 
co2 partial 39 . 5 39.1 45.9 41. 5 
pressure 
mm. Hg. 
Figure 1. The arterial blood samples necessary for blood gas 
and blood pH analysis were collected from the 
carotid artery in the ventral one-third of the 
neck. At this point the carotid artery was 
located medial to the dorsal border of the 
jugular vein. 
Ol 
Figure 2. The carotid artery could be palpated medial to the 
jugular vein. A one inch twenty gauge disposable 
needle was inserted into the lumen and arterial 
samples were collected anaerobically. 
l.L 
Figure 3 . The arterial blood samples were collected in 
disposable two and one-half milliliter syringes. 
The syringes were wetted with heparin solution 
prior to the collection procedure. The syringes 
were capped by inserting the needle into a rubbe r 
stopper to maintain anaerobic conditions. 
f7 L 
Figure 4 . A compression tourniquet was applied to forestall 
the formation of a hematoma in the carotid sheath 
or surrounding tissue after the carotid puncture. 
9L 
Figure 5. The glyceryl guaiacolate-thiamylal sodium 
solution was prepared in one liter quantities 
using sterile water as the diluent. The infusion 
of the solution was through an intravenous 
infusion apparatus and a 12 gauge trocar point 
intravenous needle. 
8l 
Figure 6. The equipment utilized for the detennination of 
blood gas tensions and blood pij was the 
Instrumentation Laboratories Model 127 Blood 
gas analyzer. 
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